
Latest headlines
Eli Lilly News
The latest Eli Lilly (LLY) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these LLY headlines next to the live Eli Lilly Fear and Greed Index.
Latest Eli Lilly Headlines60

AtaiBeckley Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AtaiBeckley Inc. - ATAI
businesswire.com · Jul 17, 2026

Deal Dispatch: Uber Buys Delivery Hero For $14.8 Billion, Eli Lilly Acquires AtaiBeckley, Lulu's Fashion Considers Strategic Alternatives
benzinga.com · Jul 17, 2026

Eli Lilly Stock Hovers In Buy Zone, Finds Key Support Amid $3 Billion Deal
investors.com · Jul 17, 2026

Eli Lilly to Boost Neuroscience Pipeline With AtaiBeckley Buyout
zacks.com · Jul 17, 2026

Looking to diversify away from AI trade? Buy these 3 stocks
invezz.com · Jul 17, 2026

Use These ETFs as Health Stocks LLY, UNH, MRK Thrive
etftrends.com · Jul 17, 2026

Eli Lilly's $3.8bn psychedelics bet is built on British science
proactiveinvestors.co.uk · Jul 17, 2026

Stock Market Today, July 16: AtaiBeckley Surges on Eli Lilly Acquisition Worth Up To $3.8 Billion
fool.com · Jul 16, 2026

AtaiBeckley stock is soaring, and it has Eli Lilly to thank
invezz.com · Jul 16, 2026

Eli Lilly Buys Psychedelics Maker Atai Beckley for $2.8 Billion to Develop DMT-Like Depression Drug
247wallst.com · Jul 16, 2026

Why Is GH Research Stock Trading Higher on Thursday?
benzinga.com · Jul 16, 2026

AtaiBeckley Shares Surge as Eli Lilly Seals $3.8B Acquisition Deal
benzinga.com · Jul 16, 2026

Medicare's $50 Weight-Loss Drug Window Opens In July: What Smart Enrollees Do Before 2027
benzinga.com · Jul 16, 2026

Meta, Vistra, T. Rowe Price and a Health Care Stock on CNBC's ‘Final Trades'
benzinga.com · Jul 16, 2026

AtaiBeckley to be acquired by Lilly in deal valued at up to $3.8 billion
proactiveinvestors.com · Jul 16, 2026

Eli Lilly to Buy AtaiBeckley for Initial $2.8 Billion
wsj.com · Jul 16, 2026

Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion as experimental treatments gain traction
cnbc.com · Jul 16, 2026

Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
prnewswire.com · Jul 16, 2026

AtaiBeckley to be acquired by Eli Lilly in deal valued at up to $3.8 billion
proactiveinvestors.com · Jul 16, 2026

This Psychedelic Pharma Stock Is Soaring 50% on Report of Eli Lilly Takeover Talks
barrons.com · Jul 16, 2026

AtaiBeckley to be acquired by Lilly in deal valued at up to $3.8 billion
proactiveinvestors.com · Jul 16, 2026

Eli Lilly nears deal to buy psychedelic drugmaker AtaiBeckley, Bloomberg News reports
reuters.com · Jul 15, 2026

RHHBY's Gazyva Gets FDA Priority Review for Label Expansion
zacks.com · Jul 15, 2026

Biogen Shares Decline After Detailed Diranersen Alzheimer's Study Data
zacks.com · Jul 15, 2026

It's been three months since Lilly launched its obesity pill. Most people are taking Novo's pill instead.
wsj.com · Jul 14, 2026

Eli Lilly (LLY) Stock Dips While Market Gains: Key Facts
zacks.com · Jul 14, 2026

Healthcare ETFs to Buy as JNJ Beats the Market With a 25% YTD Surge
zacks.com · Jul 14, 2026

Is Lilly Stock On Track To Hit $2,090?
forbes.com · Jul 14, 2026

Is This Disturbing Trend Bad News for Eli Lilly in the Billion-Dollar Obesity Drug Market?
fool.com · Jul 14, 2026

Prediction: 1 New Reason Eli Lilly Stock Could Still Be Headed Higher
247wallst.com · Jul 13, 2026

Eli Lilly Stock in Focus as Company Presents New Kisunla Data at AAIC Following Wave of Analyst Upgrades
benzinga.com · Jul 13, 2026

Here's How Much Eli Lilly's Weight-Loss Drugs Are Worth to Investors
fool.com · Jul 13, 2026

Should You Buy Eli Lilly Stock? Here's My Honest Take.
fool.com · Jul 11, 2026

Eli Lilly's $400 Billion Surge Is Reshaping Big Pharma
247wallst.com · Jul 9, 2026

Stocks Look Shaky, But This Sector is Booming (Biotech)
zacks.com · Jul 9, 2026

Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%
247wallst.com · Jul 9, 2026

Jim Cramer Says Biotech is The Hottest Group in The Market Right Now
247wallst.com · Jul 9, 2026

Here's Why Eli Lilly (LLY) is a Strong Growth Stock
zacks.com · Jul 9, 2026

Novo Nordisk's Wegovy Pill Escalates Eli Lilly Rivalry
seekingalpha.com · Jul 9, 2026

Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up?
fool.com · Jul 9, 2026

Lilly to present Alzheimer's disease diagnostic and therapeutic research at AAIC 2026, including new data on P-tau217 blood tests and amyloid-targeting treatment
prnewswire.com · Jul 9, 2026

Strong LLY News Boosts Active Healthcare ETF GDOC
etftrends.com · Jul 8, 2026

Is It Too Late to Buy Eli Lilly?
fool.com · Jul 8, 2026

The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
marketbeat.com · Jul 8, 2026

LLY Hits Another Record High: Is the Stock Too Expensive to Buy Now?
zacks.com · Jul 8, 2026

This $1,200 Stock Could Be the Next Massive Stock Split Opportunity
247wallst.com · Jul 8, 2026

Top 50 High-Quality Dividend Growth Stocks For July 2026
seekingalpha.com · Jul 8, 2026

Why Eli Lilly Stock Climbed to a Record High Today
fool.com · Jul 7, 2026

Everyone Thinks the Eli Lilly Story Is Played Out. Cramer Thinks They're Dead Wrong
247wallst.com · Jul 7, 2026

U.S. Healthcare Spending Just Hit $5.7 Trillion and Continues to Grow: 2 Stocks to Buy to Profit From the Trend
fool.com · Jul 7, 2026

Eli Lilly's Market Cap Balloons Again On This IPO's Setback
investors.com · Jul 7, 2026

Jim Cramer Calls Biotech “The Hottest Group in the Market” as He Predicts “Deals Are Going to Be Flooding the Market”
247wallst.com · Jul 7, 2026

Is It Too Late to Buy Eli Lilly Stock? Here's What $1,000 Invested Today Could Be Worth in 10 Years.
fool.com · Jul 7, 2026

Eli Lilly (LLY) Stock Slides as Market Rises: Facts to Know Before You Trade
zacks.com · Jul 6, 2026

Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know
zacks.com · Jul 6, 2026

Dividend King vs. Growth Giant: Johnson & Johnson Takes on Eli Lilly
247wallst.com · Jul 4, 2026

Eli Lilly Price Prediction: The Case for Double-Digit Upside
247wallst.com · Jul 1, 2026

Innovent, Eli Lilly Partner to Commercialize Breast Cancer Drug in China
benzinga.com · Jul 1, 2026

New Nancy Pelosi? Senator Ashley Moody Up 310% in One Year With These Stocks
247wallst.com · Jul 1, 2026

Merck, AbbVie probed by US lawmakers over China clinical trials: report
proactiveinvestors.com · Jun 30, 2026
Why Is Eli Lilly Up or Down Today?
When Eli Lilly (LLY) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a LLY move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why Eli Lilly is up or down today.
How Eli Lilly News Affects the Price
News does not move the Eli Lilly (LLY) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the Eli Lilly Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in Eli Lilly trading volume. That is the chain to watch: headline, sentiment, volume, then the LLY price.
Trade the Eli Lilly News With Sentiment
Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch Eli Lilly trading volume spike on a big story, check the Eli Lilly price history for context, follow the live LLY price, see the Eli Lilly price prediction, and read the Eli Lilly Fear and Greed Index for mood.
How do you feel about Eli Lilly?
1DFrequently asked questions
Why is Eli Lilly up or down today?
What is the latest Eli Lilly news?
Where does Eli Lilly news come from?
How often is Eli Lilly news updated?
How does Eli Lilly news relate to its Fear and Greed Index?
Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.
About CFGI
The per-asset sentiment record.
CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.
Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.